Cargando…
Amitriptyline’s anticholinergic adverse drug reactions–A systematic multiple-indication review and meta-analysis
BACKGROUND: Half the US population uses drugs with anticholinergic properties. Their potential harms may outweigh their benefits. Amitriptyline is among the most frequently prescribed anticholinergic medicinal products, is used for multiple indications, and rated as strongly anticholinergic. Our obj...
Autores principales: | Brueckle, Maria-Sophie, Thomas, Elizabeth T., Seide, Svenja Elisabeth, Pilz, Maximilian, Gonzalez-Gonzalez, Ana I., Dinh, Truc Sophia, Gerlach, Ferdinand M., Harder, Sebastian, Glasziou, Paul P., Muth, Christiane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075391/ https://www.ncbi.nlm.nih.gov/pubmed/37018325 http://dx.doi.org/10.1371/journal.pone.0284168 |
Ejemplares similares
-
Adverse drug reactions associated with amitriptyline — protocol for a systematic multiple-indication review and meta-analysis
por: Brueckle, Maria-Sophie, et al.
Publicado: (2020) -
Are Anticholinergic Symptoms a Risk Factor for Falls in Older General Practice Patients With Polypharmacy? Study Protocol for the Development and Validation of a Prognostic Model
por: Dinh, Truc Sophia, et al.
Publicado: (2021) -
Anticholinergic burden measures, symptoms, and fall-associated risk in older adults with polypharmacy: Development and validation of a prognostic model
por: Dinh, Truc Sophia, et al.
Publicado: (2023) -
Stakeholder Perspectives on the Development and Implementation of a Polypharmacy Management Program in Germany: Results of a Qualitative Study
por: Dinh, Truc Sophia, et al.
Publicado: (2022) -
Evidence-Based Decision Support for a Structured Care Program on Polypharmacy in Multimorbidity: A Guideline Upgrade Based on a Realist Synthesis
por: Dinh, Truc Sophia, et al.
Publicado: (2022)